| 1 | The Effects of N-Glycosylation on the Expression and Transport Activity of OATP1A2 and OATP2B1 | 3.2 | 6 | Citations (PDF) |
| 2 | Physiologically based pharmacokinetics modeling and transporter proteomics to predict systemic and local liver and muscle disposition of statins | 2.7 | 7 | Citations (PDF) |
| 3 | Barcode lipids for absolute quantitation of liposomes in ocular tissues | 11.0 | 7 | Citations (PDF) |
| 4 | Transporter Protein Expression of Corneal Epithelium in Rabbit and Porcine: Evaluation of Models for Ocular Drug Transport Study | 4.2 | 5 | Citations (PDF) |
| 5 | Sodium-Dependent Neutral Amino Acid Transporter 2 Can Serve as a Tertiary Carrier for l-Type Amino Acid Transporter 1-Utilizing Prodrugs | 4.2 | 8 | Citations (PDF) |
| 6 | Characterization of proteome profile data of chemicals based on data-independent acquisition MS with SWATH method | 2.2 | 1 | Citations (PDF) |
| 7 | Selective drug delivery to the retinal cells: Biological barriers and avenues | 11.0 | 59 | Citations (PDF) |
| 8 | Activation of Annexin A2 signaling at the blood–brain barrier in a mouse model of multiple sclerosis | 3.8 | 25 | Citations (PDF) |
| 9 | A human blood–arachnoid barrier atlas of transporters, receptors, enzymes, and tight junction and marker proteins: Comparison with dog and pig in absolute abundance | 3.8 | 16 | Citations (PDF) |
| 10 | Pharmacoproteomics of Brain Barrier Transporters and Substrate Design for the Brain Targeted Drug Delivery | 3.7 | 40 | Citations (PDF) |
| 11 | Regional Differences in the Absolute Abundance of Transporters, Receptors and Tight Junction Molecules at the Blood-Arachnoid Barrier and Blood-Spinal Cord Barrier among Cervical, Thoracic and Lumbar Spines in Dogs | 3.7 | 10 | Citations (PDF) |
| 12 | Proteomics-Based Transporter Identification by the PICK Method: Involvement of TM7SF3 and LHFPL6 in Proton-Coupled Organic Cation Antiport at the Blood–Brain Barrier | 4.9 | 16 | Citations (PDF) |
| 13 | Quantitative Targeted Absolute Proteomics for Better Characterization of an In Vitro Human Blood–Brain Barrier Model Derived from Hematopoietic Stem Cells | 4.6 | 19 | Citations (PDF) |
| 14 | Development of Novel Methodology and Its Application for Clarifying the Transport Function of the Blood-brain Barrier | 0.2 | 0 | Citations (PDF) |
| 15 | Identification and Validation of Combination Plasma Biomarker of Afamin, Fibronectin and Sex Hormone-Binding Globulin to Predict Pre-eclampsia | 1.5 | 19 | Citations (PDF) |
| 16 | An Atlas of the Quantitative Protein Expression of Anti-Epileptic-Drug Transporters, Metabolizing Enzymes and Tight Junctions at the Blood–Brain Barrier in Epileptic Patients | 4.9 | 17 | Citations (PDF) |
| 17 | Oxidative stress-induced activation of Abl and Src kinases rapidly induces P-glycoprotein internalization via phosphorylation of caveolin-1 on tyrosine-14, decreasing cortisol efflux at the blood–brain barrier | 4.7 | 42 | Citations (PDF) |
| 18 | Developmental changes in transporter and receptor protein expression levels at the rat blood-brain barrier based on quantitative targeted absolute proteomics | 2.1 | 28 | Citations (PDF) |
| 19 | Distinct roles of ezrin, radixin and moesin in maintaining the plasma membrane localizations and functions of human blood–brain barrier transporters | 4.7 | 22 | Citations (PDF) |
| 20 | Targeted Proteomics-Based Quantitative Protein Atlas of Pannexin and Connexin Subtypes in Mouse and Human Tissues and Cancer Cell Lines | 3.2 | 7 | Citations (PDF) |
| 21 | Distinct Transport Properties of Human Pannexin 1 and Connexin 32 Hemichannels | 3.2 | 1 | Citations (PDF) |
| 22 | Polarized hemichannel opening of pannexin 1/connexin 43 contributes to dysregulation of transport function in blood-brain barrier endothelial cells | 3.5 | 17 | Citations (PDF) |
| 23 | Abundant Expression of OCT2, MATE1, OAT1, OAT3, PEPT2, BCRP, MDR1, and xCT Transporters in Blood-Arachnoid Barrier of Pig and Polarized Localizations at CSF- and Blood-Facing Plasma Membranes | 3.6 | 45 | Citations (PDF) |
| 24 | The Multipotential of Leucine-Rich α-2 Glycoprotein 1 as a Clinicopathological Biomarker of Glioblastoma | 1.8 | 14 | Citations (PDF) |
| 25 | Establishment and validation of highly accurate formalin-fixed paraffin-embedded quantitative proteomics by heat-compatible pressure cycling technology using phase-transfer surfactant and SWATH-MS | 3.4 | 25 | Citations (PDF) |
| 26 | Gelsolin inhibits malignant phenotype of glioblastoma and is regulated by miR‐654‐5p and miR‐450b‐5p | 3.9 | 29 | Citations (PDF) |
| 27 | Comparison of Absolute Protein Abundances of Transporters and Receptors among Blood–Brain Barriers at Different Cerebral Regions and the Blood–Spinal Cord Barrier in Humans and Rats | 4.2 | 70 | Citations (PDF) |
| 28 | Determination of Intrinsic Creatine Transporter (Slc6a8) Activity and Creatine Transport Function of Leukocytes in Rats | 1.5 | 4 | Citations (PDF) |
| 29 | Quantification of ENT1 and ENT2 Proteins at the Placental Barrier and Contribution of These Transporters to Ribavirin Uptake | 3.2 | 12 | Citations (PDF) |
| 30 | Selective Protein Expression Changes of Leukocyte-Migration-Associated Cluster of Differentiation Antigens at the Blood–Brain Barrier in a Lipopolysaccharide-Induced Systemic Inflammation Mouse Model without Alteration of Transporters, Receptors or Tight Junction-Related Protein | 1.5 | 11 | Citations (PDF) |
| 31 | Amyloid beta25‐35 impairs docosahexaenoic acid efflux by down‐regulating fatty acid transport protein 1 (FATP1/SLC27A1) protein expression in human brain capillary endothelial cells | 3.8 | 18 | Citations (PDF) |
| 32 | Increased Expression of Renal Drug Transporters in a Mouse Model of Familial Alzheimer's Disease | 3.2 | 14 | Citations (PDF) |
| 33 | Organic Anion-Transporting Polypeptide 1a4 (Oatp1a4/Slco1a4) at the Blood–Arachnoid Barrier is the Major Pathway of Sulforhodamine-101 Clearance from Cerebrospinal Fluid of Rats | 4.2 | 24 | Citations (PDF) |
| 34 | Quantitative Protein Expression in the Human Retinal Pigment Epithelium: Comparison Between Apical and Basolateral Plasma Membranes With Emphasis on Transporters 2019, 60, 5022 | | 26 | Citations (PDF) |
| 35 | Identification of Blood–Brain Barrier-Permeable Proteins Derived from a Peripheral Organ: In Vivo and in Vitro Evidence of Blood-to-Brain Transport of Creatine Kinase | 4.2 | 5 | Citations (PDF) |
| 36 | Cluster of Differentiation 46 Is the Major Receptor in Human Blood–Brain Barrier Endothelial Cells for Uptake of Exosomes Derived from Brain-Metastatic Melanoma Cells (SK-Mel-28) | 4.2 | 82 | Citations (PDF) |
| 37 | [OPINION]Towards A New Sunrise in the Brain Drug Delivery Research | 0.1 | 0 | Citations (PDF) |
| 38 | Liver Zonation Index of Drug Transporter and Metabolizing Enzyme Protein Expressions in Mouse Liver Acinus | 3.6 | 29 | Citations (PDF) |
| 39 | Drug Clearance from Cerebrospinal Fluid Mediated by Organic Anion Transporters 1 (Slc22a6) and 3 (Slc22a8) at Arachnoid Membrane of Rats | 4.2 | 40 | Citations (PDF) |
| 40 | Gene therapy for Glut1‐deficient mouse using an adeno‐associated virus vector with the human intrinsic GLUT1 promoter | 2.4 | 28 | Citations (PDF) |
| 41 | ATP-Binding Cassette Transporter A Subfamily 8 Is a Sinusoidal Efflux Transporter for Cholesterol and Taurocholate in Mouse and Human Liver | 4.2 | 26 | Citations (PDF) |
| 42 | Gene expression of A6-like subgroup of ATP-binding cassette transporters in mouse brain parenchyma and microvessels | 1.5 | 6 | Citations (PDF) |
| 43 | High Expression of UGT1A1/1A6 in Monkey Small Intestine: Comparison of Protein Expression Levels of Cytochromes P450, UDP-Glucuronosyltransferases, and Transporters in Small Intestine of Cynomolgus Monkey and Human | 4.2 | 34 | Citations (PDF) |
| 44 | Evaluation of Organic Anion Transporter 1A2-knock-in Mice as a Model of Human Blood-brain Barrier | 3.6 | 16 | Citations (PDF) |
| 45 | Altered Expression of Small Intestinal Drug Transporters and Hepatic Metabolic Enzymes in a Mouse Model of Familial Alzheimer’s Disease | 4.2 | 28 | Citations (PDF) |
| 46 | Involvement of Claudin-11 in Disruption of Blood-Brain, -Spinal Cord, and -Arachnoid Barriers in Multiple Sclerosis | 3.7 | 92 | Citations (PDF) |
| 47 | Identification of blood biomarkers in glioblastoma by SWATH mass spectrometry and quantitative targeted absolute proteomics | 2.3 | 106 | Citations (PDF) |
| 48 | Gene therapy for a mouse model of glucose transporter-1 deficiency syndrome | 1.2 | 16 | Citations (PDF) |
| 49 | Actin filament‐associated protein 1 (AFAP‐1) is a key mediator in inflammatory signaling‐induced rapid attenuation of intrinsic P‐gp function in human brain capillary endothelial cells | 3.8 | 23 | Citations (PDF) |
| 50 | LC–MS/MS Based Quantitation of ABC and SLC Transporter Proteins in Plasma Membranes of Cultured Primary Human Retinal Pigment Epithelium Cells and Immortalized ARPE19 Cell Line | 4.2 | 48 | Citations (PDF) |
| 51 | Downregulation of GNA13-ERK network in prefrontal cortex of schizophrenia brain identified by combined focused and targeted quantitative proteomics | 2.4 | 47 | Citations (PDF) |
| 52 | All-trans retinoic acid enhances gemcitabine cytotoxicity in human pancreatic cancer cell line AsPC-1 by up-regulating protein expression of deoxycytidine kinase | 4.3 | 17 | Citations (PDF) |
| 53 | Application of Quantitative Targeted Absolute Proteomics to Profile Protein Expression Changes of Hepatic Transporters and Metabolizing Enzymes During Cholic Acid-Promoted Liver Regeneration | 3.2 | 8 | Citations (PDF) |
| 54 | Current Progress Toward a Better Understanding of Drug Disposition Within the Lungs: Summary Proceedings of the First Workshop on Drug Transporters in the Lungs | 3.2 | 30 | Citations (PDF) |
| 55 | MK2461, a Multitargeted Kinase Inhibitor, Suppresses the Progression of Pancreatic Cancer by Disrupting the Interaction Between Pancreatic Cancer Cells and Stellate Cells | 0.9 | 9 | Citations (PDF) |
| 56 | Scrambled Internal Standard Method for High-Throughput Protein Quantification by Matrix-Assisted Laser Desorption Ionization Tandem Mass Spectrometry | 3.4 | 7 | Citations (PDF) |
| 57 | The blood‐brain barrier fatty acid transport protein 1 (FATP1/SLC27A1) supplies docosahexaenoic acid to the brain, and insulin facilitates transport | 3.8 | 63 | Citations (PDF) |
| 58 | Inner Blood–Retinal Barrier Dominantly Expresses Breast Cancer Resistance Protein: Comparative Quantitative Targeted Absolute Proteomics Study of CNS Barriers in Pig | 4.2 | 29 | Citations (PDF) |
| 59 | Quantification of Transporter and Receptor Proteins in Dog Brain Capillaries and Choroid Plexus: Relevance for the Distribution in Brain and CSF of Selected BCRP and P-gp Substrates | 4.2 | 56 | Citations (PDF) |
| 60 | Quantitative Targeted Absolute Proteomics (QTAP)-based Pharmacoproteomics: The Importance of International Collaboration | 0.2 | 0 | Citations (PDF) |
| 61 | Abnormal <i>N</i>-Glycosylation of a Novel Missense Creatine Transporter Mutant, G561R, Associated with Cerebral Creatine Deficiency Syndromes Alters Transporter Activity and Localization | 1.5 | 14 | Citations (PDF) |
| 62 | Cell-Type-Specific Spatiotemporal Expression of Creatine Biosynthetic Enzyme S-adenosylmethionine:guanidinoacetate N-methyltransferase in Developing Mouse Brain | 3.4 | 11 | Citations (PDF) |
| 63 | Large‐scale multiplex absolute protein quantification of drug‐metabolizing enzymes and transporters in human intestine, liver, and kidney microsomes by SWATH‐MS: Comparison with MRM/SRM and HR‐MRM/PRM | 3.1 | 126 | Citations (PDF) |
| 64 | Correlation of Organic Cation/Carnitine Transporter 1 and Multidrug Resistance-Associated Protein 1 Transport Activities With Protein Expression Levels in Primary Cultured Human Tracheal, Bronchial, and Alveolar Epithelial Cells | 3.2 | 18 | Citations (PDF) |
| 65 | Quantitative Atlas of Cytochrome P450, UDP-Glucuronosyltransferase, and Transporter Proteins in Jejunum of Morbidly Obese Subjects | 4.2 | 76 | Citations (PDF) |
| 66 | Global and Targeted Proteomics of Prostate Cancer Cell Secretome: Combination of 2-Dimensional Image-Converted Analysis of Liquid Chromatography and Mass Spectrometry and In Silico Selection Selected Reaction Monitoring Analysis | 3.2 | 12 | Citations (PDF) |
| 67 | Quantitative Targeted Absolute Proteomics of Transporters and Pharmacoproteomics-Based Reconstruction of P-Glycoprotein Function in Mouse Small Intestine | 4.2 | 18 | Citations (PDF) |
| 68 | Oral Morphine Pharmacokinetic in Obesity: The Role of P-Glycoprotein, MRP2, MRP3, UGT2B7, and CYP3A4 Jejunal Contents and Obesity-Associated Biomarkers | 4.2 | 26 | Citations (PDF) |
| 69 | Identification of IGFBP2 and IGFBP3 As Compensatory Biomarkers for CA19-9 in Early-Stage Pancreatic Cancer Using a Combination of Antibody-Based and LC-MS/MS-Based Proteomics | 2.3 | 95 | Citations (PDF) |
| 70 | Quantitative Determination of Luminal and Abluminal Membrane Distributions of Transporters in Porcine Brain Capillaries by Plasma Membrane Fractionation and Quantitative Targeted Proteomics | 3.2 | 77 | Citations (PDF) |
| 71 | Quantitative targeted absolute proteomics of rat blood–cerebrospinal fluid barrier transporters: comparison with a human specimen | 3.8 | 102 | Citations (PDF) |
| 72 | Major involvement of Na+‐dependent multivitamin transporter (SLC5A6/SMVT) in uptake of biotin and pantothenic acid by human brain capillary endothelial cells | 3.8 | 111 | Citations (PDF) |
| 73 | Validation of a P-Glycoprotein (P-gp) Humanized Mouse Model by Integrating Selective Absolute Quantification of Human MDR1, Mouse Mdr1a and Mdr1b Protein Expressions with In Vivo Functional Analysis for Blood-Brain Barrier Transport | 2.3 | 33 | Citations (PDF) |
| 74 | Contribution of Pannexin 1 and Connexin 43 Hemichannels to Extracellular Calcium–Dependent Transport Dynamics in Human Blood-Brain Barrier Endothelial Cells | 3.3 | 40 | Citations (PDF) |
| 75 | Drug Transporter Protein Quantification of Immortalized Human Lung Cell Lines Derived from Tracheobronchial Epithelial Cells (Calu-3 and BEAS2-B), Bronchiolar–Alveolar Cells (NCI-H292 and NCI-H441), and Alveolar Type II-like Cells (A549) by Liquid Chromatography–Tandem Mass Spectrometry | 3.2 | 48 | Citations (PDF) |
| 76 | Quantitative Targeted Proteomics of Pancreatic Cancer: Deoxycytidine Kinase Protein Level Correlates to Progression-Free Survival of Patients Receiving Gemcitabine Treatment | 4.2 | 40 | Citations (PDF) |
| 77 | Quantitative targeted absolute proteomics for 28 human transporters in plasma membrane of Caco-2 cell monolayer cultured for 2, 3, and 4 weeks | 2.1 | 43 | Citations (PDF) |
| 78 | Involvement of Insulin-Degrading Enzyme in Insulin- and Atrial Natriuretic Peptide-Sensitive Internalization of Amyloid-β Peptide in Mouse Brain Capillary Endothelial Cells | 2.6 | 33 | Citations (PDF) |
| 79 | Blood-Brain Barrier Pharmacoproteomics-Based Reconstruction of the In Vivo Brain Distribution of P-Glycoprotein Substrates in Cynomolgus Monkeys | 3.3 | 56 | Citations (PDF) |
| 80 | Pharmacoproteomics-Based Reconstruction of In Vivo P-Glycoprotein Function at Blood-Brain Barrier and Brain Distribution of Substrate Verapamil in Pentylenetetrazole-Kindled Epilepsy, Spontaneous Epilepsy, and Phenytoin Treatment Models | 3.6 | 29 | Citations (PDF) |
| 81 | Quantitative targeted proteomics for understanding the blood–brain barrier: towards pharmacoproteomics | 2.0 | 44 | Citations (PDF) |
| 82 | Validation of uPA/SCID Mouse with Humanized Liver as a Human Liver Model: Protein Quantification of Transporters, Cytochromes P450, and UDP-Glucuronosyltransferases by LC-MS/MS | 3.6 | 42 | Citations (PDF) |
| 83 | Genomic Knockout of Endogenous Canine P-Glycoprotein in Wild-Type, Human P-Glycoprotein and Human BCRP Transfected MDCKII Cell Lines by Zinc Finger Nucleases | 3.7 | 30 | Citations (PDF) |
| 84 | Functional expression of a proton-coupled organic cation (H+/OC) antiporter in human brain capillary endothelial cell line hCMEC/D3, a human blood–brain barrier model | 5.3 | 72 | Citations (PDF) |
| 85 | Contributions of Degradation and Brain-to-blood Elimination Across the Blood—Brain Barrier to Cerebral Clearance of Human Amyloid-β Peptide(1-40) in Mouse Brain | 4.7 | 18 | Citations (PDF) |
| 86 | Identification of Transporters Associated with Etoposide Sensitivity of Stomach Cancer Cell Lines and Methotrexate Sensitivity of Breast Cancer Cell Lines by Quantitative Targeted Absolute Proteomics | 2.6 | 23 | Citations (PDF) |
| 87 | Quantitative expression of human drug transporter proteins in lung tissues: Analysis of regional, gender, and interindividual differences by liquid chromatography–tandem mass spectrometry | 3.2 | 82 | Citations (PDF) |
| 88 | Quantitative Targeted Absolute Proteomic Analysis of Transporters, Receptors and Junction Proteins for Validation of Human Cerebral Microvascular Endothelial Cell Line hCMEC/D3 as a Human Blood–Brain Barrier Model | 4.2 | 221 | Citations (PDF) |
| 89 | Blood-to-brain influx transport of nicotine at the rat blood?brain barrier: Involvement of a pyrilamine-sensitive organic cation transport process | 3.5 | 55 | Citations (PDF) |
| 90 | Critical role of TXNIP in oxidative stress, DNA damage and retinal pericyte apoptosis under high glucose: Implications for diabetic retinopathy | 3.1 | 108 | Citations (PDF) |
| 91 | Quantitative Targeted Absolute Proteomics-Based Large-Scale Quantification of Proline-Hydroxylated α-Fibrinogen in Plasma for Pancreatic Cancer Diagnosis | 3.4 | 39 | Citations (PDF) |
| 92 | Quantitative Atlas of Blood–Brain Barrier Transporters, Receptors, and Tight Junction Proteins in Rats and Common Marmoset | 3.2 | 235 | Citations (PDF) |
| 93 | Establishment and characterization of spinal cord microvascular endothelial cell lines | 1.0 | 23 | Citations (PDF) |
| 94 | Trans-chromosomic mice containing a human CYP3A cluster for prediction of xenobiotic metabolism in humans | 2.9 | 81 | Citations (PDF) |
| 95 | Quantitative targeted absolute proteomics (QTAP)-based rational research on the human blood-brain barrier transport | 0.1 | 0 | Citations (PDF) |
| 96 | Simultaneous Absolute Protein Quantification of Transporters, Cytochromes P450, and UDP-Glucuronosyltransferases as a Novel Approach for the Characterization of Individual Human Liver: Comparison with mRNA Levels and Activities | 3.6 | 402 | Citations (PDF) |
| 97 | Absolute Quantification and Differential Expression of Drug Transporters, Cytochrome P450 Enzymes, and UDP-Glucuronosyltransferases in Cultured Primary Human Hepatocytes | 3.6 | 128 | Citations (PDF) |
| 98 | Quantitative Proteomics of Transporter Expression in Brain Capillary Endothelial Cells Isolated from P-Glycoprotein (P-gp), Breast Cancer Resistance Protein (Bcrp), and P-gp/Bcrp Knockout Mice | 3.6 | 120 | Citations (PDF) |
| 99 | Attenuation of Phosphorylation by Deoxycytidine Kinase is Key to Acquired Gemcitabine Resistance in a Pancreatic Cancer Cell Line: Targeted Proteomic and Metabolomic Analyses in PK9 Cells | 3.7 | 23 | Citations (PDF) |
| 100 | Recurrent anaplastic meningioma treated by sunitinib based on results from quantitative proteomics | 3.1 | 11 | Citations (PDF) |
| 101 | Transcriptomic and Quantitative Proteomic Analysis of Transporters and Drug Metabolizing Enzymes in Freshly Isolated Human Brain Microvessels | 4.2 | 355 | Citations (PDF) |
| 102 | GSK-3β/CREB axis mediates IGF-1-induced ECM/adhesion molecule expression, cell cycle progression and monolayer permeability in retinal capillary endothelial cells: Implications for diabetic retinopathy | 4.1 | 26 | Citations (PDF) |
| 103 | Blood-Brain Barrier (BBB) Pharmacoproteomics: Reconstruction of In Vivo Brain Distribution of 11 P-Glycoprotein Substrates Based on the BBB Transporter Protein Concentration, In Vitro Intrinsic Transport Activity, and Unbound Fraction in Plasma and Brain in Mice | 3.3 | 125 | Citations (PDF) |
| 104 | In-vivo Blood-brain Barrier Transport of a Novel Adrenocorticotropic Hormone Analogue, Ebiratide, Demonstrated by Brain Microdialysis and Capillary Depletion Methods | 2.9 | 4 | Citations (PDF) |
| 105 | Experimental evidence of characteristic tissue distribution of adriamycin. Tissue DNA concentration as a determinant | 2.9 | 14 | Citations (PDF) |
| 106 | Specific binding and clearance of [3H]dynorphin (1–13) in the perfused rat lung: an application of the multiple-indicator dilution method | 2.9 | 3 | Citations (PDF) |
| 107 | Physiological pharmacokinetics of Mactam antibiotics: penicillin V distribution and elimination after intravenous administration in rats | 2.9 | 6 | Citations (PDF) |
| 108 | In-vitro Evidence for Carrier-mediated Uptake of Acidic Drugs by Isolated Bovine Brain Capillaries | 2.9 | 3 | Citations (PDF) |
| 109 | A carrier-mediated transport system for benzylpenicillin in isolated hepatocytes | 2.9 | 1 | Citations (PDF) |
| 110 | Intestinal brush-border transport of the oral cephalosporin antibiotic, cefdinir, mediated by dipeptide and monocarboxylic acid transport systems in rabbits | 2.9 | 14 | Citations (PDF) |
| 111 | Molecular-weight-dependent, Anionic-substrate-preferential Transport of β-Lactam Antibiotics via Multidrug Resistance-associated Protein 4 | 2.1 | 30 | Citations (PDF) |
| 112 | Quantitative targeted absolute proteomics of human blood–brain barrier transporters and receptors | 3.8 | 801 | Citations (PDF) |
| 113 | Amyloid‐β peptide(1‐40) elimination from cerebrospinal fluid involves low‐density lipoprotein receptor‐related protein 1 at the blood‐cerebrospinal fluid barrier | 3.8 | 57 | Citations (PDF) |
| 114 | Atrial Natriuretic Peptide is Eliminated from the Brain by Natriuretic Peptide Receptor-C-Mediated Brain-to-Blood Efflux Transport at the Blood—Brain Barrier | 4.7 | 18 | Citations (PDF) |
| 115 | Attenuation of prostaglandin E2 elimination across the mouse blood-brain barrier in lipopolysaccharide-induced inflammation and additive inhibitory effect of cefmetazole | 5.3 | 38 | Citations (PDF) |
| 116 | Proteome analysis of rat serum proteins adsorbed onto synthetic octacalcium phosphate crystals | 2.4 | 56 | Citations (PDF) |
| 117 | Targeting choroid plexus epithelia and ventricular ependyma for drug delivery to the central nervous system | 2.1 | 28 | Citations (PDF) |
| 118 | 1α,25-Dihydroxyvitamin D3 enhances cerebral clearance of human amyloid-β peptide(1-40) from mouse brain across the blood-brain barrier | 5.3 | 94 | Citations (PDF) |
| 119 | Simultaneous Absolute Quantification of 11 Cytochrome P450 Isoforms in Human Liver Microsomes by Liquid Chromatography Tandem Mass Spectrometry with In Silico Target Peptide Selection | 3.2 | 160 | Citations (PDF) |
| 120 | Quantitative Membrane Protein Expression at the Blood–Brain Barrier of Adult and Younger Cynomolgus Monkeys | 3.2 | 215 | Citations (PDF) |
| 121 | Diphenhydramine Active Uptake at the Blood–Brain Barrier and Its Interaction with Oxycodone in vitro and in Vivo | 3.2 | 89 | Citations (PDF) |
| 122 | Reliability and Robustness of Simultaneous Absolute Quantification of Drug Transporters, Cytochrome P450 Enzymes, and Udp-Glucuronosyltransferases in Human Liver Tissue by Multiplexed MRM/Selected Reaction Monitoring Mode Tandem Mass Spectrometry with Nano-Liquid Chromatography | 3.2 | 56 | Citations (PDF) |
| 123 | Functional characterization of Rat Plasma Membrane Monoamine Transporter in the Blood–Brain and Blood–Cerebrospinal Fluid Barriers | 3.2 | 43 | Citations (PDF) |
| 124 | Quantitative Targeted Absolute Proteomics-Based Adme Research as A New Path to Drug Discovery and Development: Methodology, Advantages, Strategy, and Prospects | 3.2 | 129 | Citations (PDF) |
| 125 | Inner Blood–Retinal Barrier Mediates L-Isomer-Predominant Transport of Serine | 3.2 | 11 | Citations (PDF) |
| 126 | Peripheral nerve pericytes modify the blood–nerve barrier function and tight junctional molecules through the secretion of various soluble factors | 4.1 | 134 | Citations (PDF) |
| 127 | Saturable uptake of cefixime, a new oral cephalosporin without an α-amino group, by the rat intestine | 2.9 | 10 | Citations (PDF) |
| 128 | Expression of ABC-type transport proteins in human platelets | 1.2 | 33 | Citations (PDF) |
| 129 | Regulation of extracellular-superoxide dismutase in rat retina pericytes | 6.2 | 10 | Citations (PDF) |
| 130 | Epidermal growth factor targeting of bacteriophage to the choroid plexus for gene delivery to the central nervous system via cerebrospinal fluid | 2.5 | 11 | Citations (PDF) |
| 131 | Drug–drug interaction between oxycodone and adjuvant analgesics in blood–brain barrier transport and antinociceptive effect | 3.2 | 22 | Citations (PDF) |
| 132 | Establishment of a new conditionally immortalized human brain microvascular endothelial cell line retaining an in vivo blood–brain barrier function | 4.1 | 115 | Citations (PDF) |
| 133 | Lack of brain‐to‐blood efflux transport activity of low‐density lipoprotein receptor‐related protein‐1 (LRP‐1) for amyloid‐β peptide(1–40) in mouse: involvement of an LRP‐1‐independent pathway | 3.8 | 47 | Citations (PDF) |
| 134 | Is P-glycoprotein Involved in Amyloid-β Elimination Across the Blood–Brain Barrier in Alzheimer’s Disease? | 4.7 | 20 | Citations (PDF) |
| 135 | Involvement of Multidrug Resistance-Associated Protein 4 in Efflux Transport of Prostaglandin E2 across Mouse Blood-Brain Barrier and Its Inhibition by Intravenous Administration of Cephalosporins | 3.3 | 35 | Citations (PDF) |
| 136 | The HMG-CoA Reductase Inhibitor Pravastatin Stimulates Insulin Secretion through Organic Anion Transporter Polypeptides | 2.1 | 21 | Citations (PDF) |
| 137 | Inhibition of TXNIP expression in vivo blocks early pathologies of diabetic retinopathy | 8.5 | 130 | Citations (PDF) |
| 138 | In-vivo and In-vitro Evidence of a Carrier-mediated Efflux Transport System for Oestrone-3-sulphate across the Blood-Cerebrospinal Fluid Barrier | 2.9 | 15 | Citations (PDF) |
| 139 | Characterization of immortalized choroid plexus epithelial cell lines for studies of transport processes across the blood-cerebrospinal fluid barrier | 2.3 | 28 | Citations (PDF) |
| 140 | Polyol Formation in Cell Lines of Rat Retinal Capillary Pericytes and Endothelial Cells (TR-rPCT and TR-iBRB) | 1.9 | 16 | Citations (PDF) |
| 141 | Depletion of Vitamin E Increases Amyloid β Accumulation by Decreasing Its Clearances from Brain and Blood in a Mouse Model of Alzheimer Disease | 2.2 | 99 | Citations (PDF) |
| 142 | Human Platelets Express Organic Anion-Transporting Peptide 2B1, an Uptake Transporter for Atorvastatin | 3.6 | 61 | Citations (PDF) |
| 143 | Roles of Inner Blood-Retinal Barrier Organic Anion Transporter 3 in the Vitreous/Retina-to-Blood Efflux Transport of p-Aminohippuric Acid, Benzylpenicillin, and 6-Mercaptopurine | 3.3 | 67 | Citations (PDF) |
| 144 | SLCO4C1 Transporter Eliminates Uremic Toxins and Attenuates Hypertension and Renal Inflammation | 0.4 | 137 | Citations (PDF) |
| 145 | Thioredoxin interacting protein (TXNIP) induces inflammation through chromatin modification in retinal capillary endothelial cells under diabetic conditions | 4.1 | 232 | Citations (PDF) |
| 146 | The blood–brain barrier transport and cerebral distribution of guanidinoacetate in rats: involvement of creatine and taurine transporters | 3.8 | 50 | Citations (PDF) |
| 147 | Beneficial Effects of Estrogen in a Mouse Model of Cerebrovascular Insufficiency | 2.3 | 36 | Citations (PDF) |
| 148 | mRNA expression levels of tight junction protein genes in mouse brain capillary endothelial cells highly purified by magnetic cell sorting | 3.8 | 144 | Citations (PDF) |
| 149 | Quantitative Atlas of Membrane Transporter Proteins: Development and Application of a Highly Sensitive Simultaneous LC/MS/MS Method Combined with Novel In-silico Peptide Selection Criteria | 3.7 | 467 | Citations (PDF) |
| 150 | Characterization of the Mechanism of Zidovudine Uptake by Rat Conditionally Immortalized Syncytiotrophoblast Cell Line TR-TBT | 3.7 | 22 | Citations (PDF) |
| 151 | Efflux of a suppressive neurotransmitter, GABA, across the blood-brain barrier | 3.8 | 82 | Citations (PDF) |
| 152 | Peripheral Nerve pericytes originating from the blood–nerve barrier expresses tight junctional molecules and transporters as barrier‐forming cells | 4.1 | 104 | Citations (PDF) |
| 153 | The blood‐cerebrospinal fluid barrier is a major pathway of cerebral creatinine clearance: involvement of transporter‐mediated process | 3.8 | 36 | Citations (PDF) |
| 154 | Expression and possible role of creatine transporter in the brain and at the blood‐cerebrospinal fluid barrier as a transporting protein of guanidinoacetate, an endogenous convulsant | 3.8 | 57 | Citations (PDF) |
| 155 | Fgf2 is expressed in human and murine embryonic choroid plexus and affects choroid plexus epithelial cell behaviour | 2.3 | 19 | Citations (PDF) |
| 156 | BMP signaling through BMPRIA in astrocytes is essential for proper cerebral angiogenesis and formation of the blood–brain-barrier | 2.2 | 54 | Citations (PDF) |
| 157 | Expression of nuclear receptor mRNA and liver X receptor-mediated regulation of ABC transporter A1 at rat blood–brain barrier | 3.5 | 48 | Citations (PDF) |
| 158 | ATP-binding cassette transporter A1 (ABCA1) deficiency does not attenuate the brain-to-blood efflux transport of human amyloid-β peptide (1–40) at the blood–brain barrier | 3.5 | 51 | Citations (PDF) |
| 159 | Investigation of the Role of Breast Cancer Resistance Protein (Bcrp/Abcg2) on Pharmacokinetics and Central Nervous System Penetration of Abacavir and Zidovudine in the Mouse | 3.6 | 67 | Citations (PDF) |
| 160 | The Low Density Lipoprotein Receptor-related Protein 1 Mediates Uptake of Amyloid β Peptides in an in Vitro Model of the Blood-Brain Barrier Cells | 2.2 | 111 | Citations (PDF) |
| 161 | Involvement of the Pyrilamine Transporter, a Putative Organic Cation Transporter, in Blood-Brain Barrier Transport of Oxycodone | 3.6 | 176 | Citations (PDF) |
| 162 | Enhancement of Zidovudine Uptake by Dehydroepiandrosterone Sulfate in Rat Syncytiotrophoblast Cell Line TR-TBT 18d-1 | 3.6 | 17 | Citations (PDF) |
| 163 | Altered Expression of Basement Membrane-related Molecules in Rat Brain Pericyte, Endothelial, and Astrocyte Cell Lines after Transforming Growth Factor-β1 Treatment | 2.1 | 33 | Citations (PDF) |
| 164 | Insulin Facilitates the Hepatic Clearance of Plasma Amyloid β-Peptide (1–40) by Intracellular Translocation of Low-Density Lipoprotein Receptor-Related Protein 1 (LRP-1) to the Plasma Membrane in Hepatocytes | 2.6 | 115 | Citations (PDF) |
| 165 | Function and regulation of taurine transport at the inner blood–retinal barrier | 2.5 | 69 | Citations (PDF) |
| 166 | Hyperammonemia induces transport of taurine and creatine and suppresses claudin-12 gene expression in brain capillary endothelial cells in vitro | 3.5 | 57 | Citations (PDF) |
| 167 | Inducible Nitric Oxide Synthase Isoform Is a Key Mediator of Leukostasis and Blood-Retinal Barrier Breakdown in Diabetic Retinopathy 2007, 48, 5257 | | 235 | Citations (PDF) |
| 168 | Exogenous expression of claudin-5 induces barrier properties in cultured rat brain capillary endothelial cells | 4.1 | 164 | Citations (PDF) |
| 169 | 24S-hydroxycholesterol induces cholesterol release from choroid plexus epithelial cells in an apical- and apoE isoform-dependent manner concomitantly with the induction of ABCA1 and ABCG1 expression | 3.8 | 64 | Citations (PDF) |
| 170 | Brain‐to‐blood elimination of 24S‐hydroxycholesterol from rat brain is mediated by organic anion transporting polypeptide 2 (oatp2) at the blood–brain barrier | 3.8 | 38 | Citations (PDF) |
| 171 | Cerebral clearance of human amyloid‐β peptide (1–40) across the blood–brain barrier is reduced by self‐aggregation and formation of low‐density lipoprotein receptor‐related protein‐1 ligand complexes | 3.8 | 81 | Citations (PDF) |
| 172 | A functional in vitro model of rat blood–brain barrier for molecular analysis of efflux transporters | 2.5 | 153 | Citations (PDF) |
| 173 | Establishing a Method to Isolate Rat Brain Capillary Endothelial Cells by Magnetic Cell Sorting and Dominant mRNA Expression of Multidrug Resistance-associated Protein 1 and 4 in Highly Purified Rat Brain Capillary Endothelial Cells | 3.7 | 32 | Citations (PDF) |
| 174 | Contribution of Carrier-Mediated Transport Systems to the Blood–Brain Barrier as a Supporting and Protecting Interface for the Brain; Importance for CNS Drug Discovery and Development | 3.7 | 461 | Citations (PDF) |
| 175 | Multichannel Liquid Chromatography–Tandem Mass Spectrometry Cocktail Method for Comprehensive Substrate Characterization of Multidrug Resistance-Associated Protein 4 Transporter | 3.7 | 66 | Citations (PDF) |
| 176 | Induction of Endoplasmic Reticulum Stress in Retinal Pericytes by Glucose Deprivation | 2.1 | 80 | Citations (PDF) |
| 177 | In vivo delivery of small interfering RNA targeting brain capillary endothelial cells | 2.1 | 33 | Citations (PDF) |
| 178 | Functional characterization of the brain-to-blood efflux clearance of human amyloid-β peptide (1–40) across the rat blood–brain barrier | 2.1 | 116 | Citations (PDF) |
| 179 | Modulation and Compensation of the mRNA Expression of Energy Related Transporters in the Brain of Glucose Transporter 1-Deficient Mice | 1.5 | 33 | Citations (PDF) |
| 180 | Involvement of organic anion transporters in the efflux of uremic toxins across the blood–brain barrier | 3.8 | 59 | Citations (PDF) |
| 181 | ATP-Binding Cassette Transporter G2 Mediates the Efflux of Phototoxins on the Luminal Membrane of Retinal Capillary Endothelial Cells | 3.7 | 74 | Citations (PDF) |
| 182 | Establishment and characterization of conditionally immortalized endothelial cell lines from the thoracic duct and inferior vena cava of tsA58/EGFP double-transgenic rats | 2.7 | 22 | Citations (PDF) |
| 183 | Retinal-specific ATP-binding cassette transporter (ABCR/ABCA4) is expressed at the choroid plexus in rat brain | 3.8 | 28 | Citations (PDF) |
| 184 | Selective gene silencing of rat ATP-binding cassette G2 transporter in an in vitro blood-brain barrier model by short interfering RNA | 3.8 | 15 | Citations (PDF) |
| 185 | Distinct spatio-temporal expression of ABCA and ABCG transporters in the developing and adult mouse brain | 3.8 | 130 | Citations (PDF) |
| 186 | PKC/MAPK signaling suppression by retinal pericyte conditioned medium prevents retinal endothelial cell proliferation | 4.1 | 16 | Citations (PDF) |
| 187 | Dominant expression of androgen receptors and their functional regulation of organic anion transporter 3 in rat brain capillary endothelial cells; Comparison of gene expression between the blood-brain and -retinal barriers | 4.1 | 39 | Citations (PDF) |
| 188 | Platelet‐derived growth factor‐BB (PDGF‐BB) induces differentiation of bone marrow endothelial progenitor cell‐derived cell line TR‐BME2 into mural cells, and changes the phenotype | 4.1 | 45 | Citations (PDF) |
| 189 | Evidence for creatine biosynthesis in Müller glia | 5.0 | 43 | Citations (PDF) |
| 190 | Donepezil, tacrine and α-phenyl-n-tert-butyl nitrone (PBN) inhibit choline transport by conditionally immortalized rat brain capillary endothelial cell lines (TR-BBB) | 6.9 | 31 | Citations (PDF) |
| 191 | Differential Contributions of rOat1 (Slc22a6) and rOat3 (Slc22a8) to the in Vivo Renal Uptake of Uremic Toxins in Rats | 3.7 | 55 | Citations (PDF) |
| 192 | Vascular EndotheliumSelective Gene Induction by Tie2 Promoter/Enhancer in the Brain and Retina of a Transgenic Rat | 3.7 | 18 | Citations (PDF) |
| 193 | L-Type Amino Acid Transporter 1–Mediatedl-Leucine Transport at the Inner Blood–Retinal Barrier 2005, 46, 2522 | | 93 | Citations (PDF) |
| 194 | Increased JNK Phosphorylation and Oxidative Stress in Response to Increased Glucose Flux through Increased GLUT1 Expression in Rat Retinal Endothelial Cells 2005, 46, 3403 | | 23 | Citations (PDF) |
| 195 | Pharmacokinetic simulator with three-dimensional graphical models: Sociotechnological interface of pharmacokinetics for medical personnel, patients, and medicinal chemists | 0.2 | 0 | Citations (PDF) |
| 196 | Physiological pharmacokinetics and membrane transport for drug delivery research | 0.2 | 0 | Citations (PDF) |
| 197 | Characterization of the organic cation transporter SLC22A16: A doxorubicin importer | 2.1 | 147 | Citations (PDF) |
| 198 | In vitro models for the blood–brain barrier | 2.6 | 386 | Citations (PDF) |
| 199 | Brain-to-blood transporters for endogenous substrates and xenobiotics at the blood-brain barrier: An overview of biology and methodology | 3.4 | 75 | Citations (PDF) |
| 200 | Blood-Brain Barrier Permeability of Novel [d-Arg2]Dermorphin (1-4) Analogs: Transport Property Is Related to the Slow Onset of Antinociceptive Activity in the Central Nervous System | 3.3 | 18 | Citations (PDF) |
| 201 | Efficient transfer of receptor-associated protein (RAP) across the blood-brain barrier | 2.4 | 150 | Citations (PDF) |
| 202 | Brain Insulin Impairs Amyloid- (1-40) Clearance from the Brain | 3.7 | 97 | Citations (PDF) |
| 203 | Mouse Reduced in Osteosclerosis Transporter Functions as an Organic Anion Transporter 3 and Is Localized at Abluminal Membrane of Blood-Brain Barrier | 3.3 | 77 | Citations (PDF) |
| 204 | Vitamin C Transport in Oxidized Form across the Rat Blood–Retinal Barrier 2004, 45, 1232 | | 93 | Citations (PDF) |
| 205 | Distinct cellular expressions of creatine synthetic enzyme GAMT and creatine kinases uCK‐Mi and CK‐B suggest a novel neuron–glial relationship for brain energy homeostasis | 3.5 | 159 | Citations (PDF) |
| 206 | A pericyte‐derived angiopoietin‐1 multimeric complex induces occludin gene expression in brain capillary endothelial cells through Tie‐2 activation in vitro | 3.8 | 327 | Citations (PDF) |
| 207 | Blood‐to‐retina transport of creatine via creatine transporter (CRT) at the rat inner blood–retinal barrier | 3.8 | 62 | Citations (PDF) |
| 208 | Localization of organic anion transporting polypeptide 3 (oatp3) in mouse brain parenchymal and capillary endothelial cells | 3.8 | 54 | Citations (PDF) |
| 209 | Organic anion transporter 3 is involved in the brain-to-blood efflux transport of thiopurine nucleobase analogs | 3.8 | 81 | Citations (PDF) |
| 210 | Functional expression of rat ABCG2 on the luminal side of brain capillaries and its enhancement by astrocyte-derived soluble factor(s) | 3.8 | 136 | Citations (PDF) |
| 211 | A new in vitro model for blood?cerebrospinal fluid barrier transport studies: an immortalized choroid plexus epithelial cell line derived from the tsA58 SV40 large T-antigen gene transgenic rat | 15.4 | 31 | Citations (PDF) |
| 212 | The l-isomer-selective transport of aspartic acid is mediated by ASCT2 at the blood-brain barrier | 3.8 | 61 | Citations (PDF) |
| 213 | Transporter mRNA Expression in a Conditionally Immortalized Rat Small Intestine Epithelial Cell Line (TR-SIE) | 2.1 | 9 | Citations (PDF) |
| 214 | New approaches to in vitro models of blood–brain barrier drug transport | 6.6 | 160 | Citations (PDF) |
| 215 | Recombinant arginine deiminase as a differential modulator of inducible (iNOS) and endothelial (eNOS) nitric oxide synthetase activity in cultured endothelial cells | 5.1 | 33 | Citations (PDF) |
| 216 | Expression and regulation of L-cystine transporter, system xc?, in the newly developed rat retinal M�ller cell line (TR-MUL) | 5.0 | 90 | Citations (PDF) |
| 217 | Rat brain pericyte cell lines expressing ?2-adrenergic receptor, angiotensin II receptor type 1A, klotho, and CXCR4 mRNAs despite having endothelial cell markers | 4.1 | 23 | Citations (PDF) |
| 218 | Blood-brain barrier transport of a novel µ1-specific opioid peptide, H-Tyr-d-Arg-Phe-β-Ala-OH (TAPA) | 3.8 | 35 | Citations (PDF) |
| 219 | Rat Organic Anion Transporter 3 (rOAT3) is Responsible for Brain-to-Blood Efflux of Homovanillic Acid at the Abluminal Membrane of Brain Capillary Endothelial Cells | 4.7 | 161 | Citations (PDF) |
| 220 | In Vitro Study of the Functional Expression of Organic Anion Transporting Polypeptide 3 at Rat Choroid Plexus Epithelial Cells and Its Involvement in the Cerebrospinal Fluid-to-Blood Transport of Estrone-3-Sulfate | 2.6 | 63 | Citations (PDF) |
| 221 | Molecular mechanisms of drug influx and efflux transport at the blood-brain barrier | 0.1 | 12 | Citations (PDF) |
| 222 | Brain and Heart Specific Alteration of Methamphetamine (MAP) Distribution in MAP-Sensitized Rat. | 1.5 | 7 | Citations (PDF) |
| 223 | Establishment of Conditionally Immortalized Rat Retinal Pericyte Cell Lines (TR-rPCT) and Their Application in a Co-culture System Using Retinal Capillary Endothelial Cell Line (TR-iBRB2) | 3.8 | 41 | Citations (PDF) |
| 224 | Rat Organic Anion Transporter 3 (rOAT3) Is Responsible for Brain-to-Blood Efflux of Homovanillic Acid at the Abluminal Membrane of Brain Capillary Endothelial Cells | 4.7 | 65 | Citations (PDF) |
| 225 | ATA2 Is Predominantly Expressed as System A at the Blood-Brain Barrier and Acts as Brain-to-Blood Efflux Transport forl-Proline | 2.6 | 73 | Citations (PDF) |
| 226 | Enhancement of l-Cystine Transport Activity and Its Relation to xCT Gene Induction at the Blood-Brain Barrier by Diethyl Maleate Treatment | 3.3 | 56 | Citations (PDF) |
| 227 | mRNA Expression and Amino Acid Transport Characteristics of Cultured Human Brain Microvascular Endothelial Cells (hBME) | 2.1 | 23 | Citations (PDF) |
| 228 | In Vivo Evidence for Brain-to-Blood Efflux Transport of Valproic Acid across the Blood–Brain Barrier | 2.5 | 27 | Citations (PDF) |
| 229 | Localization of norepinephrine and serotonin transporter in mouse brain capillary endothelial cells | 2.1 | 80 | Citations (PDF) |
| 230 | Newly developed rat brain pericyte cell line, TR-PCT1, responds to transforming growth factor-β1 and β-glycerophosphate | 3.9 | 36 | Citations (PDF) |
| 231 | Polarized glucose transporters and mRNA expression properties in newly developed rat syncytiotrophoblast cell lines, TR-TBTs | 4.1 | 41 | Citations (PDF) |
| 232 | Blood-Brain Barrier Is Involved in the Efflux Transport of a Neuroactive Steroid, Dehydroepiandrosterone Sulfate, via Organic Anion Transporting Polypeptide 2 | 3.8 | 132 | Citations (PDF) |
| 233 | Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain | 3.8 | 212 | Citations (PDF) |
| 234 | Internalization of basic fibroblast growth factor at the mouse blood-brain barrier involves perlecan, a heparan sulfate proteoglycan | 3.8 | 67 | Citations (PDF) |
| 235 | Regulation of taurine transport at the blood-brain barrier by tumor necrosis factor-α, taurine and hypertonicity | 3.8 | 117 | Citations (PDF) |
| 236 | Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney | 5.3 | 143 | Citations (PDF) |
| 237 | Recent advances in the brain-to-blood efflux transport across the blood–brain barrier | 4.8 | 48 | Citations (PDF) |
| 238 | Coordinating Etk/Bmx activation and VEGF upregulation to promote cell survival and proliferation | 6.5 | 59 | Citations (PDF) |
| 239 | The Blood–Brain Barrier Creatine Transporter is a Major Pathway for Supplying Creatine to the Brain | 4.7 | 186 | Citations (PDF) |
| 240 | The Blood???Brain Barrier Creatine Transporter Is a Major Pathway for Supplying Creatine to the Brain | 4.7 | 60 | Citations (PDF) |
| 241 | ATA2 Is Predominantly Expressed as System A at the Blood-Brain Barrier and Acts as Brain-to-Blood Efflux Transport forl-Proline | 2.6 | 3 | Citations (PDF) |
| 242 | Conditionally Immortalized Retinal Capillary Endothelial Cell Lines (TR-iBRB) Expressing Differentiated Endothelial Cell Functions Derived from a Transgenic Rat | 2.5 | 149 | Citations (PDF) |
| 243 | Activation of Carrier-Mediated Transport of l-Cystine at the Blood–Brain and Blood–Retinal Barriers in Vivo | 2.5 | 33 | Citations (PDF) |
| 244 | Acidic Amino Acid Transport Characteristics of a Newly Developed Conditionally Immortalized Rat Type 2 Astrocyte Cell Line (TR-AST). | 3.8 | 30 | Citations (PDF) |
| 245 | Conditionally Immortalized Cell Lines as a New In Vitro Model for the Study of Barrier Functions | 1.5 | 87 | Citations (PDF) |
| 246 | Blood-Brain Barrier Produces Significant Efflux of L-Aspartic Acid but Not D-Aspartic Acid | 3.8 | 89 | Citations (PDF) |
| 247 | Title is missing! | 3.7 | 64 | Citations (PDF) |
| 248 | Title is missing! | 3.7 | 19 | Citations (PDF) |
| 249 | Title is missing! | 3.7 | 104 | Citations (PDF) |
| 250 | GAT2/BGT-1 as a System Responsible for the Transport of γ-Aminobutyric Acid at the Mouse Blood–Brain Barrier | 4.7 | 178 | Citations (PDF) |
| 251 | Brain-to-blood efflux transport of estrone-3-sulfate at the blood-brain barrier in rats | 4.5 | 37 | Citations (PDF) |
| 252 | Conditionally immortalized brain capillary endothelial cell lines established from a transgenic mouse harboring temperature-sensitive simian virus 40 large T-antigen gene | 1.7 | 64 | Citations (PDF) |
| 253 | mRNA Expression and Transport Characterization of Conditionally Immortalized Rat Brain Capillary Endothelial Cell Lines; a Newin vitroBBB Model for Drug Targeting | 3.9 | 107 | Citations (PDF) |
| 254 | The blood–brain barrier efflux transporters as a detoxifying system for the brain | 15.4 | 95 | Citations (PDF) |
| 255 | Effects of Arginine-Vasopressin Fragment 4–9 on Rodent Cholinergic Systems | 2.3 | 22 | Citations (PDF) |
| 256 | Differences in the hepatobiliary transport of two quinolone antibiotics, grepafloxacin and lomefloxacin, in the rat 1999, 20, 151-158 | | 16 | Citations (PDF) |
| 257 | A Novel Stromal Cell-Dependent B Lymphoid Stem-Like Cell Line That Induces Immunoglobulin Gene Rearrangement | 1.5 | 6 | Citations (PDF) |
| 258 | Modulation of the Tumor Disposition of Vinca Alkaloids by PSC 833 In Vitro and In Vivo | 3.3 | 1 | Citations (PDF) |
| 259 | Efflux of Taurocholic Acid Across the Blood-Brain Barrier: Interaction with Cyclic Peptides | 3.3 | 20 | Citations (PDF) |
| 260 | Brain-to-blood active transport of β-alanine across the blood-brain barrier | 2.7 | 17 | Citations (PDF) |
| 261 | Cell density-dependent mitogenic effect and -independent cellular handling of epidermal growth factor in primary cultured rat hepatocytes | 4.2 | 8 | Citations (PDF) |
| 262 | Role of efflux transport across the blood-brain barrier and blood-cerebrospinal fluid barrier on the disposition of xenobiotics in the central nervous system | 15.4 | 93 | Citations (PDF) |
| 263 | Efficient Delivery of Circulating Poliovirus to the Central Nervous System Independently of Poliovirus Receptor | 2.3 | 112 | Citations (PDF) |
| 264 | Distributed Model Analysis of 3′-Azido-3′-Deoxythymidine and 2′,3′-Dideoxyinosine Distribution in Brain Tissue and Cerebrospinal Fluid | 3.3 | 19 | Citations (PDF) |
| 265 | P-Glycoprotein Mediates the Efflux of Quinidine across the Blood-Brain Barrier | 3.3 | 50 | Citations (PDF) |
| 266 | Kinetic Evidence for Active Efflux Transport across the Blood-Brain Barrier of Quinolone Antibiotics | 3.3 | 23 | Citations (PDF) |
| 267 | In Vivo and In Vitro Evidence for Nonrestricted Transport of 2′,7′-Bis(2-Carboxyethyl)-5(6)-Carboxyfluorescein Tetraacetoxymethyl Ester at the Blood-Brain Barrier | 3.3 | 10 | Citations (PDF) |
| 268 | Kinetic Analysis of the Disposition of MRK16, an Anti-P-glycoprotein Monoclonal Antibody, in Tumors: Comparison Between in Vitro and in Vivo Disposition | 3.3 | 4 | Citations (PDF) |
| 269 | Selective Brain to Blood Efflux Transport of para-Aminohippuric Acid across the Blood-Brain Barrier:In Vivo Evidence by Use of the Brain Efflux Index Method | 3.3 | 19 | Citations (PDF) |
| 270 | In Vivo Evidence for Carrier-Mediated Efflux Transport of 3′-Azido-3′-Deoxythymidine and 2′,3′-Dideoxyinosine Across the Blood-Brain Barrier via a Probenecid-Sensitive Transport System | 3.3 | 33 | Citations (PDF) |
| 271 | Carrier-Mediated Hepatic Uptake of Quinolone Antibiotics in the Rat | 3.3 | 19 | Citations (PDF) |
| 272 | Title is missing! | 3.7 | 15 | Citations (PDF) |
| 273 | Title is missing! | 3.7 | 21 | Citations (PDF) |
| 274 | Sodium and Chloride Ion‐Dependent Transport of β‐Alanine Across the Blood‐Brain Barrier | 3.8 | 36 | Citations (PDF) |
| 275 | Title is missing! | 3.7 | 20 | Citations (PDF) |
| 276 | Title is missing! | 3.7 | 9 | Citations (PDF) |
| 277 | Na+- and Cl−-Dependent transport of taurine at the blood-brain barrier | 5.1 | 89 | Citations (PDF) |
| 278 | Drug delivery to the brain utilizing blood-brain barrier transport systems | 11.0 | 20 | Citations (PDF) |
| 279 | Title is missing! | 3.7 | 43 | Citations (PDF) |
| 280 | Title is missing! | 3.7 | 145 | Citations (PDF) |
| 281 | Title is missing! | 3.7 | 200 | Citations (PDF) |
| 282 | Title is missing! | 3.7 | 44 | Citations (PDF) |
| 283 | Functional expression of intestinal dipeptide/β-lactam antibiotic transporter in Xenopus laevis oocytes | 5.1 | 28 | Citations (PDF) |
| 284 | Uptake of drugs and expression of P-glycoprotein in the rat 9L glioma | 1.3 | 17 | Citations (PDF) |
| 285 | Restricted transport of cyclosporin A across the blood-brain barrier by a multidrug transporter, P-glycoprotein | 5.1 | 165 | Citations (PDF) |
| 286 | Blood-Brain Barrier Transport of Ebiratide and Its Uptake by Cerebral Neuronal Cells | 4.0 | 0 | Citations (PDF) |
| 287 | P-glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells | 4.5 | 271 | Citations (PDF) |
| 288 | Title is missing! | 3.7 | 44 | Citations (PDF) |
| 289 | Receptor-mediated endocytosis of A14-125I-insulin by the nonfiltering perfused rat kidney | 2.0 | 17 | Citations (PDF) |
| 290 | Title is missing! | 3.7 | 74 | Citations (PDF) |
| 291 | Title is missing! | 3.7 | 33 | Citations (PDF) |
| 292 | Receptor-recycling model of clearance and distribution of insulin in the perfused mouse liver | 7.5 | 44 | Citations (PDF) |
| 293 | pH-Dependent Intestinal Transport of Monocarboxylic Acids: Carrier-Mediated and H+-Cotransport Mechanism Versus pH-Partition Hypothesis | 3.2 | 45 | Citations (PDF) |
| 294 | Degradation Kinetics of (±)-4′-Ethyl-2-methyl-3-(1-pyrrolidinyl)propiophenone Hydrochloride (HY-770) and Structure–Stability Relationship among its Analogues in Aqueous Solution | 3.2 | 2 | Citations (PDF) |
| 295 | Serum Protein Binding of Lomefloxacin, a New Antimicrobial Agent, and Its Related Quinolones | 3.2 | 16 | Citations (PDF) |
| 296 | Age-Related Change in Tissue-to-Plasma Partition Coefficient of Cefazolin for Noneliminating Organs in the Rat | 3.2 | 17 | Citations (PDF) |
| 297 | Effects of Atropine on Adrenergic Responsiveness and Reflex Vasoconstriction in Humans | 0.3 | 0 | Citations (PDF) |
| 298 | Differential Binding of Testosterone and Estradiol to Isoforms of Sex Hormone-Binding Globulin: Selective Alteration of Estradiol Binding in Cirrhosis* | 4.0 | 37 | Citations (PDF) |
| 299 | Differential binding of thyroxine and triiodothyronine to acidic isoforms of thyroid hormone binding globulin in human serum | 2.4 | 14 | Citations (PDF) |
| 300 | Restricted Transport of 3'-Azido-3'-Deoxythymidine and Dideoxynucleosides Through the Blood-Brain Barrier | 3.7 | 110 | Citations (PDF) |
| 301 | Stereospecificity of Triiodothyronine Transport into Brain, Liver, and Salivary Gland: Role of Carrier- and Plasma Protein-Mediated Transport* | 2.5 | 27 | Citations (PDF) |
| 302 | β-Lactam antibiotics and transport via the dipeptide carrier system across the intestinal brush-border membrane | 5.1 | 49 | Citations (PDF) |
| 303 | H+ gradient-dependent and carrier-mediated transport of cefixime, a new cephalosporin antibiotic, across brush-border membrane vesicles from rat small intestine. | 3.3 | 24 | Citations (PDF) |
| 304 | Uptake of benzylpenicillin, cefpiramide and cefazolin by freshly prepared rat hepatocytes | 5.1 | 58 | Citations (PDF) |
| 305 | Theoretical consideration of drug distribution kinetics in a noneliminating organ: Comparison between a “homogeneous (well-stirred)” model and “nonhomogeneous (tube)” model | 0.7 | 8 | Citations (PDF) |
| 306 | Interaction of Doxorubicin with Nuclei Isolated from Rat Liver and Kidney | 3.2 | 16 | Citations (PDF) |
| 307 | Pharmacokinetic Study on the Mechanism of Tissue Distribution of Doxorubicin: Interorgan and Interspecies Variation of Tissue-To-Plasma Partition Coefficients in Rats, Rabbits, and Guinea Pigs | 3.2 | 79 | Citations (PDF) |
| 308 | Physiologically Based Pharmacokinetic Model for β-Lactam Antibiotics I: Tissue Distribution and Elimanation Rates | 3.2 | 150 | Citations (PDF) |
| 309 | Carbenicillin Prodrugs: Kinetics of Intestinal Absorption Competing Degradation of the α-Esters of Carbenicillin and Prediction of Prodrug Absorbability from Quantitative Structure-Absorption Rate Relationship | 3.2 | 8 | Citations (PDF) |
| 310 | Carbenicillin Prodrugs: Stability Kinetics of α-phenyl and α-indanyl Esters in Aqueous Solution | 3.2 | 12 | Citations (PDF) |
| 311 | Enhanced Polarity of Sulfonamide Metformin Derivatives Increases Cellular Uptake and Apoptosis-Inducing Effects in Human Breast Cancer Cells | 4.2 | 1 | Citations (PDF) |
| 312 | PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL FOR CEFAZOLIN IN RABBITS AND ITS PRELIMINARY EXTRAPOLATION TO MAN | 3.6 | 1 | Citations (PDF) |
| 313 | A disintegrin and metalloproteinase with thrombospondin motifs 18 (ADAMTS18) cleaves fibronectin and negatively regulates its fibrillogenesis | 2.2 | 1 | Citations (PDF) |
| 314 | Elucidating the roles of TM7SF3 and LHFPL6 in the putative H+/OC antiporter function in the human brain capillary endothelial cell line, hCMEC/D3 | 4.3 | 0 | Citations (PDF) |
| 315 | Role of the arachnoid mater organic anion and cation transporters in the clearance of prostaglandin D2 and metformin from the cerebrospinal fluid in rats | 2.1 | 0 | Citations (PDF) |
